Cephalovac EWTThis page contains information on Cephalovac EWT for veterinary use.
The information provided typically includes the following:
- Cephalovac EWT Indications
- Warnings and cautions for Cephalovac EWT
- Direction and dosage information for Cephalovac EWT
Cephalovac EWTThis treatment applies to the following species:
Eastern & Western, Killed Virus
Cephalovac EWT Indications
For the vaccination of healthy horses 6 months of age or older as an aid in the prevention of diseases caused by Eastern and Western Encephalomyelitis, and tetanus.
Administration and Dosage: Shake well before use. Using aseptic technique, inoculate horses intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3-4 weeks using a different injection site. Revaccinate annually and prior to anticipated exposure with a single 1 mL intramuscular dose.
PrecautionsStore at 35-45°F (2-7°C). Protect from freezing. Do not vaccinate within 60 days before slaughter. Anaphylactoid reactions may occur following use. Antidote: Epinephrine.
This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy in normal, healthy, immunocompetent animals. This level of performance may be affected by conditions such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies, or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions.
For Veterinary Use Only
Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 64506
U.S. Veterinary License No. 124
1 Dose/1 mL
10 x 1 dose (1 mL) syringes
3239 SATELLITE BLVD., DULUTH, GA, 30096
|Every effort has been made to ensure the accuracy of the Cephalovac EWT information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2018 North American Compendiums. Updated: 2018-02-26